CONJUALL
Live / Registered — Registered (as of 20 Aug 2024)
What this means for you
Registered since 20 Aug 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97191384
- Registration number
- 7477524
- Mark type
- Stylized text
- Filed
- 27 Dec 2021
- Published for opposition
- 04 Jun 2024
- Registered
- 20 Aug 2024
- Attorney of record
- Corey K. Cho
Goods and services
- Class 005 — Pharmaceuticals: Medicinal preparations for prevention and treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases, namely, antibodies, antibody conjugates and active ingredients and antibody conjugates; chemical reagents for medical use, especially chemical reagents for linking molecules for medical use; colostral antibodies and the chemical modifications and conjugates thereof for medical purposes and medical laboratory tests; drug delivery agents consisting of compounds that facilitate delivery of pharmaceuticals for the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; biological preparations for pharmaceutical purposes for the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; Chemical preparations for pharmaceutical purposes for the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; medical pharmaceuticals for use in relation to the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; medical molecular diagnostic reagents for use in relation to the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; biopharmaceuticals for use in relation to the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; pharmaceutical preparations for treatment of rare diseases
- Class 042 — Scientific and technological services: Scientific study and research in the field(s) of research on the subject of pharmaceuticals; development of pharmaceutical preparations and medicines; medical and pharmaceutical research services; biological research and analysis; chemical research and analysis; biochemical research and analysis; and scientific research in the nature of conducting clinical trials for others
Owner
- LEGOCHEM BIOSCIENCES, INC., Daejeon, KR
- LEGOCHEM BIOSCIENCES, INC., Daejeon, KR
- LEGOCHEM BIOSCIENCES, INC., Daejeon, KR
Prosecution history
- 20 Aug 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 20 Aug 2024 — REGISTERED-PRINCIPAL REGISTER
- 04 Jun 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 04 Jun 2024 — PUBLISHED FOR OPPOSITION
- 15 May 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 02 May 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 02 May 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 02 May 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 02 May 2024 — ASSIGNED TO LIE
- 12 Dec 2023 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
- 27 Sept 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 27 Sept 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 27 Sept 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 14 Sept 2023 — NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
- 14 Sept 2023 — INQUIRY TO SUSPENSION E-MAILED